815631-56-2 Usage
General Description
4-Fluoro-2-methylphenylboronic acid pinacol ester is a chemical compound with the molecular formula C12H15BF. It is a boronic acid derivative and is commonly used in organic synthesis as a reagent for the formation of carbon-carbon and carbon-heteroatom bonds. The pinacol ester group provides stability and solubility in organic solvents, making it useful for a variety of chemical reactions. 4-FLUORO-2-METHYLPHENYLBORONIC ACID, PINACOL ESTER is often used in the pharmaceutical industry and in the development of agrochemicals, as well as in the production of electronic materials. It is important to handle and store this compound with care, as it is corrosive and can be harmful if ingested or inhaled.
Check Digit Verification of cas no
The CAS Registry Mumber 815631-56-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,5,6,3 and 1 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 815631-56:
(8*8)+(7*1)+(6*5)+(5*6)+(4*3)+(3*1)+(2*5)+(1*6)=162
162 % 10 = 2
So 815631-56-2 is a valid CAS Registry Number.
InChI:InChI=1/C13H18BFO2/c1-9-8-10(15)6-7-11(9)14-16-12(2,3)13(4,5)17-14/h6-8H,1-5H3
815631-56-2Relevant articles and documents
Undirected ortho-selectivity in C–H borylation of arenes catalyzed by NHC platinum(0) complexes
Rzhevskiy, Sergey A.,Topchiy, Maxim A.,Golenko, Yulia D.,Gribanov, Pavel S.,Sterligov, Grigorii K.,Kirilenko, Nikita Yu.,Ageshina, Alexandra A.,Bermeshev, Maxim V.,Nechaev, Mikhail S.,Asachenko, Andrey F.
, p. 569 - 571 (2020/10/09)
Borylation of arenes with bis(pinacolato)diboron catalyzed by sterically encumbered NHC platinum complexes proceeds predominantly at ortho-position even in the absence of a directing group (o: m: p ratio up to 10: 3: 1). The similar borylation with pinacolborane would proceed less selectively.
NK1 ANTAGONIST
-
Page/Page column 17, (2010/02/09)
The invention is to a compound exhibiting neurokinin inhibitory properties, a pharmaceutical composition comprising same and a method of treatment for neurokinin-meditated conditions.Formula (I)
